CNS Trial is a clinical research site located in Long Beach, California, United States 90806.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
CNS Trial has participated in 2 clinical trials.
Therapeutic areas: Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1, Spinocerebellar Ataxia Genotype Type 2.
Sponsors: Biohaven Pharmaceuticals, Inc., Neurana Pharmaceuticals, Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CNS Trial has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CNS Trial has 2 clinical trials on record. Their work covers Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1, Spinocerebellar Ataxia Genotype Type 2.
CNS Trial has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.